BiotechTube
CeraVx

CeraVx

Leiden, Netherlands· Est.
ceravx.bio
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CeraVx is a privately held, pre-revenue biotech company pioneering a novel ceramic microneedle array patch (CeraMap) platform for intradermal drug and vaccine delivery. Its core technology leverages biocompatible ceramic materials and semiconductor manufacturing techniques to create patches that are painless, require lower drug doses, and target skin-resident immune cells. The company, which recently emerged from stealth in late 2024, is positioned as a platform technology provider seeking partnerships with biopharma companies to advance its patches through research and clinical development.

Infectious DiseaseBroad Therapeutic

Technology Platform

Proprietary ceramic microneedle array patch (CeraMap) platform for intradermal delivery of vaccines, therapeutics, and other agents. Features biocompatible, inert ceramic needles with nanoporous structures for drug loading and tunable release.

Opportunities

The CeraMap platform addresses major needs in biopharma: dose-sparing (5-20x less drug), pain-free administration, and simplified logistics.
This creates significant opportunities in pandemic preparedness, global health, and patient-centric chronic disease management.
The technology's compatibility with diverse drug classes allows for multiple partnership avenues across the industry.

Risk Factors

Key risks include the technical challenge of scaling a novel ceramic manufacturing process and demonstrating robust clinical efficacy.
The company faces intense competition in the microneedle space and is reliant on securing partnerships for funding and development, making its progress highly dependent on external validation and collaboration.

Competitive Landscape

CeraVx competes in the growing microneedle patch sector with companies like Vaxxas (high-density microarray patch), Micron Biomedical (dissolving microneedles), and others. Its differentiation lies in the use of inert ceramic, which may offer advantages in drug stability, mechanical strength, and tunable release kinetics compared to polymer or sugar-based dissolving needles.

More companies in Drug Delivery & Formulation →More companies in Netherlands →